How does rat anti-mouse CD1d antibody reveal the mechanism of gut lipid immune regulation in serotonin secretion?

1. How do intestinal neuroendocrine and immune systems interact to regulate physiological functions?

The intestine is not only an organ for digestion and absorption but also a crucial neuroendocrine and immune regulation center in the human body. Among intestinal epithelial cells, there exists a special type of endocrine cell—enterochromaffin cells, which are the primary source of serotonin in the gut. Serotonin, as a key neurotransmitter and hormone, plays a central role in regulating intestinal motility, secretion, sensation, and systemic physiological functions (such as hemostasis, metabolism, and bone development). Meanwhile, the intestinal immune system continuously monitors luminal contents, where CD1d molecules, as critical antigen-presenting proteins, can present lipid antigens to innate immune cells like invariant natural killer T (iNKT) cells. Recent studies have revealed close cross-talk between the neuroendocrine and immune systems in the gut. However, the specific pathways through which lipid antigens precisely regulate serotonin release from enterochromaffin cells via immune mechanisms remain unclear. In research on this complex mechanism, rat anti-mouse CD1d monoclonal antibodies, which can specifically recognize and interfere with mouse CD1d molecule function, have become indispensable key tools.

2. What is the key role of CD1d molecules in lipid-induced intestinal motility?

The study first explored the role of CD1d in lipid-regulated intestinal motility. Using genetically engineered mouse models, researchers specifically knocked out the CD1d gene in epithelial cells. The results showed that, compared to wild-type mice, mice with epithelial-specific CD1d deficiency exhibited significantly prolonged intestinal transit time and impaired peristaltic function. When stimulated with the specific CD1d ligand α-galactosylceramide, wild-type mice showed rapid colonic contraction, while this response was markedly weakened in epithelial CD1d-deficient mice. Further ex vivo experiments using calcium imaging revealed that α-galactosylceramide treatment significantly activated neuronal activity in the myenteric plexus, but this activation effect disappeared completely after removing the epithelial layer. These findings collectively indicate that CD1d molecules expressed by intestinal epithelial cells are essential bridges for lipid antigens to activate intestinal neurons and regulate intestinal motility. In such mechanistic studies, rat anti-mouse CD1d antibodies can be used for flow cytometry or immunohistochemistry to precisely verify CD1d expression and absence in different cell types, providing molecular-level evidence for functional research.

3. How does CD1d signaling activate serotonin release from enterochromaffin cells?

Researchers further investigated the specific activation mechanism of CD1d signaling in enterochromaffin cells. Experiments found that when CD1d binds to its ligand, it triggers phosphorylation of tyrosine at position 332 in its intracellular domain. This phosphorylation event recruits and activates the downstream signaling protein—proline-rich tyrosine kinase 2 (Pyk2). Using rat anti-mouse CD1d antibodies for cross-linking stimulation, both human enterochromaffin cell lines and mouse primary intestinal organoids showed significantly increased Pyk2 phosphorylation levels, accompanied by enhanced serotonin secretion. When Pyk2-specific inhibitors were used or CD1d tyrosine phosphorylation site mutants were constructed, CD1d-mediated calcium influx and serotonin release in enterochromaffin cells were significantly suppressed. In-depth electrophysiological analysis revealed that the CD1d-Pyk2 signaling axis could inhibit the activity of potassium channel Kv1.2, leading to cell membrane depolarization, which opens voltage-gated calcium channels, triggers calcium influx, and ultimately induces serotonin secretion. This series of studies clearly delineates the complete signaling pathway from CD1d recognition of lipid antigens to serotonin release by enterochromaffin cells. In this process, rat anti-mouse CD1d antibodies are not only used to verify CD1d expression and localization but also serve as stimulation tools to mimic ligand binding and precisely activate this signaling pathway in vitro to study downstream events.

4. How do gut microbiota sphingolipids regulate serotonin secretion via CD1d?

Gut microbiota metabolites, particularly lipid components, are important environmental factors influencing host physiology. Bacteroides fragilis, a key commensal bacterium, synthesizes a class of unique bacterial sphingolipids. Studies using germ-free mouse mono-colonization models found that compared to mice colonized with wild-type B. fragilis, mice colonized with sphingolipid-deficient mutant B. fragilis showed increased iNKT cell numbers in the colon, significantly elevated serum serotonin levels, accelerated intestinal motility, and shortened bleeding time (indicating enhanced platelet activity). This suggests that bacterial-derived sphingolipids may negatively regulate serotonin release via a CD1d-dependent pathway. Sphingolipids from wild-type bacteria might competitively inhibit the activation of the CD1d-iNKT cell axis by host lipid antigens, thereby "downregulating" enterochromaffin cell activity. To test this hypothesis, rat anti-mouse CD1d antibodies can play a key role: by administering blocking antibodies in vivo to inhibit CD1d function and observing whether the inhibitory effect of bacterial sphingolipids disappears; or using these antibodies to isolate and identify bacterial lipid components bound to CD1d, thereby analyzing the microbial-host immune-neuroendocrine interaction network at the molecular level.

5. Which manufacturers provide rat anti-mouse CD1d antibodies?

Hangzhou Start Biotech Co., Ltd. has independently developed the "Alexa Fluor® 647 Rat Anti-Mouse CD1d Antibody (S-R665)" (Catalog No.: S0B5187), a ready-to-use flow detection antibody with high fluorescence brightness, excellent specificity, and stability. This product uses highly purified rat anti-mouse CD1d monoclonal antibodies labeled with Alexa Fluor® 647 fluorescent dye through optimized processes. It efficiently and specifically binds to mouse CD1d molecules, enabling sensitive identification and fine typing of key immune cell subsets (such as NKT cells and certain antigen-presenting cells) in multicolor flow cytometry (FACS) analysis.

Technical Support: We provide detailed product instructions, including recommended sample processing methods, staining conditions, and multicolor panel suggestions for various research scenarios (e.g., NKT cell analysis, B cell typing). Our technical team offers professional consultation on flow cytometry experimental design and optimization.

Hangzhou Start Biotech Co., Ltd. is committed to providing high-performance, high-quality multicolor flow detection antibodies for mouse model immunology research. For more details about the "Alexa Fluor® 647 Rat Anti-Mouse CD1d Antibody" (Catalog No. S0B5187), technical parameters, or sample requests, please feel free to contact us.

Product Information

Disclaimer: This article partially utilizes artificial intelligence assistance in its creation. If any content involves copyright or intellectual property issues, please let us know and we promise to verify and remove it as soon as possible.

ANT BIO PTE. LTD. – Empowering Scientific Breakthroughs

At ANTBIO, we are committed to advancing life science research through high-quality, reliable reagents and comprehensive solutions. Our specialized sub-brands (Absin, Starter, UA) cover a full spectrum of research needs, from general reagents and kits to antibodies and recombinant proteins. With a focus on innovation, quality, and customer-centricity, we strive to be your trusted partner in unlocking scientific mysteries and driving medical progress. Explore our product portfolio today and elevate your research to new heights.